AIM Pharmakon, Inc. Company Profile

23:11 EST 24th November 2017 | BioPortfolio

News Articles [2 Associated News Articles listed on BioPortfolio]

Ex-Pharmacy Compliance Director pleads guilty to introducing illegal drugs into the market

Caprice Bearden, a 63-year old ex-Director of Compliance for an Indiana-based Pharmakon, has been found guilty of introducing adulterated drugs into the market and obstructing the US FDA’s lawful fu...

Merck-Aktie: Wachstumspotenzial der Sparten Life Science und Performance Materials wird unterschätzt! Aktienanalyse

Zürich - Merck-Aktienanalyse von Analyst Michael Leuchten von der UBS: Michael Leuchten, Analyst der UBS, nimmt in einer aktuellen Aktienanalyse die Coverage für die Aktie des Chemie- und Pharmakon....

Drugs and Medications [0 Results]


PubMed Articles [0 Results]


Clinical Trials [0 Results]


More Information about "AIM Pharmakon, Inc." on BioPortfolio

We have published hundreds of AIM Pharmakon, Inc. news stories on BioPortfolio along with dozens of AIM Pharmakon, Inc. Clinical Trials and PubMed Articles about AIM Pharmakon, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of AIM Pharmakon, Inc. Companies in our database. You can also find out about relevant AIM Pharmakon, Inc. Drugs and Medications on this site too.

Quick Search

Corporate Database Quicklinks

Searches Linking to this Company Record